Aug 20, 2025 12:00
BBOT - BridgeBio Oncology Therapeutics, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 11.01 0.94 (8.54%) | --- | --- | --- | --- | 0.94 (8.54%) | --- | --- |
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 67.06
- VWAP:
- 11.93
- RVol:
- 0.3962
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price increase 1m | 11.85 +0.16 (+1.33%) | Oct 15 15:27 |
| 1m | Price increase 1m | 11.53 +0.23 (+2.0%) | Oct 15 13:58 |
| 1m | Price increase 1m | 11.59 +0.29 (+2.57%) | Oct 15 11:43 |
| 1m | Price increase 1m | 11.42 +0.15 (+1.38%) | Oct 15 10:17 |
| 1m | Price decrease 1m | 11.27 -0.12 (-1.01%) | Oct 15 10:15 |